Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvement by Akihiko Matsumine et al.
RESEARCH Open Access
Minimally invasive surgery using
intraoperative electron-beam radiotherapy
for the treatment of soft tissue sarcoma of
the extremities with tendon involvement
Akihiko Matsumine1*, Masaya Tsujii1, Tomoki Nakamura1, Kunihiro Asanuma1, Takao Matsubara1, Takuya Kakimoto1,
Yuki Yada1, Akinori Takada2, Noriko Ii2, Yoshihito Nomoto2 and Akihiro Sudo1
Abstract
Background: When a soft tissue sarcoma (STS) is located at the distal part of an extremity and involves the tendon,
a wide excision usually causes severe functional disability. We therefore developed a minimally invasive surgical
technique using intraoperative electron-beam radiotherapy (IOERT) to reduce the incidence of post-operative
functional disability in patients with peri-/intra-tendinous STS. We assessed the clinical outcomes of the novel
minimally invasive surgery.
Methods: The study population included five patients who received treatment for distal extremity STSs. After
elevating the tumor mass, including the tendon and nerve from the tumor bed with a wide margin, a lead board
was inserted beneath the tumor mass to shield the normal tissue. IOERT (25–50 Gy) was then applied, and the
tumor excised with care taken to maintain the continuity of the tendon.
Results: In a desmoid patient, local recurrence was observed outside the irradiated field. No cases of neuropathy or
bone necrosis were observed. The mean limb function score was excellent in all patients. None of the high-grade
sarcoma patients had local recurrence or distant metastasis.
Conclusions: Although the current study is only a pilot study with a small number of patients, it shows that this
minimally invasive procedure has the potential to become a standard treatment option for selected patients.
Trial registration: H17-250 (registered 2 November 2005) and H25-250 (modified from H17-250, registered 5
December 2013)
Keywords: Minimally invasive surgery, Intraoperative electron-beam radiotherapy (IOERT), Soft tissue sarcoma,
Tendon involvement, Clinical outcome
Background
Although the recent progression of multidisciplinary
treatments, such as chemotherapy agents, molecular
target drugs, and ion beam radiotherapy, have enabled
the application of various therapeutic options in the
treatment of soft tissue sarcoma (STS), the resection of
the tumor with a wide margin is the standard and most
reliable treatment for patients with extremity STS [1, 2].
The surgical resection of STS with a wide margin
sometimes causes functional disability of the affected
limb, because a wide resection requires the excision of
adjacent structures, including the bones, nerves, arteries,
veins, and tendons [1–4]. The wide excision of even
small tumors will usually result in severe functional dis-
ability if they are peri-/intra-tendinously located at the
distal part of an extremity [1, 3–5]. The active motion of
the finger and wrist may be impaired in patients’ fore-
arm tumors. If the tumor is located at the distal leg, the
active motion of the toe and ankle may be impaired.
* Correspondence: matsumin@clin.medic.mie-u.ac.jp
1Department of Orthopaedic Surgery, Mie University Graduate School of
Medicine, 2-174 Edobashi, Tsu City, Mie 514-8507, Japan
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Matsumine et al. World Journal of Surgical Oncology  (2016) 14:214 
DOI 10.1186/s12957-016-0968-4
Surgeons have attempted to reduce the degree of func-
tional disability after the resection of peri-/intra-tendinous
STSs by various reconstruction methods, including ten-
don transfers [5, 6], autologous tendon grafts [7–10], allo-
genic tendon grafts [11], and functional muscle transfers
[3, 4, 6, 7, 12]. However, these procedures require the
muscle to act as a power source, and muscle function may
disappear after a wide excision [4, 7, 12]. Tendon transfer
causes severe soft tissue adhesion due to the sub-optimal
condition of the tissue bed after resection [13]. Although a
tendon graft may be a treatment option, the harvest of the
tendon results in surgical stress at the donor site [7, 11].
The clinical outcome of the reconstruction of the soft tis-
sue defect should be measured not only by stable wound
coverage but also by preservation of a patient’s limb func-
tion [6]. However, the impact of reconstructive surgery
has been limited [12].
External-beam radiation therapy (EBRT) given before
or after surgery is the standard treatment, especially in
high-grade (G2–3), deep, and less than 5-cm lesions [2].
Preoperative EBRT is associated with lower rates of late
toxicity and may allow a lower radiation dose, because
the intact vascular supply renders a tumor more sensitive
to RT. Post-operative EBRT is typically administered at
60–68 Gy over 6 to 7 weeks. Advantages of post-operative
EBRT include the availability to conduct a full pathological
review of the tumor prior to making a decision about ad-
juvant therapy. However, the most critical problem associ-
ated with EBRT is that it can cause a number of common,
well-described side effects, such as muscle fibrosis, severe
neuropathy, joint contracture, vascular obstruction, and
lymphatic edema [14, 15]. These adverse effects of EBRT
sometimes compromise the quality of life of patients.
Intraoperative radiotherapy (IORT) was first performed
by Abe et al. at Kyoto University in the early 1960s [16].
IORT is designed to provide a large radiation dose to a
target tissue while sparing normal tissues. Intraoperative
electron-beam radiotherapy (IOERT) refers to the applica-
tion of electron-beam radiation in this procedure. The
therapeutic advantage is that IOERT can deliver a highly
effective radiation dose to a specific target, while the
dose to healthy structures can be limited by surgical
displacement or shielding [17]. There is a large amount
of published work on the use of IOERT in combination
with surgery with/without EBRT in the treatment of
soft tissue sarcomas of the retroperitoneum or extrem-
ities [14, 18–27]. The typical IOERT doses range from
10 to 20 Gy. Doses of 10–12.5 Gy are often used for pa-
tients with microscopic residual or close margins. How-
ever, for patients with gross residual disease, higher
doses of up to 20 Gy are used. Recently, the combin-
ation of IOERT and EBRT has been recommended and
many institutes perform IOERT (15 to 20 Gy) followed
by EBRT (35 to 50 Gy) after surgery [23]. The 5-year
local control rates in patients with retroperitoneal STSs
and extremity STSs were reported to be 40–65 %
[22, 24, 25] and 63–91 % [14, 17–21, 27, 28], respectively.
Although conventional IOERT has been used to
achieve limb preservation without local recurrence, the
improvement of limb function has not usually been
considered in the assessment of treatment outcomes.
We therefore developed a minimally invasive surgical
technique using IOERT to reduce the incidence of post-
operative functional disability in patients with peri-/intra-
tendinous STS.
This surgical procedure consists of the four following
steps: 1) the elevation of the tumor mass including the
tendon and nerve from the tumor bed with a wide mar-
gin, 2) IOERT after the insertion of a lead board beneath
the tumor mass to shield the normal tissue, 3) tumor
excision maintaining the continuity of the tendon, and if
necessary, 4) reconstruction of the soft tissue defect
using a vascularized/local musculocutaneous flap. The
purpose of the present study is to clarify the clinical out-
comes of this novel surgical technique.
Methods
Patients
Five patients with peri-/intra-tendinous STSs of the dis-
tal extremities underwent surgical treatment in combin-
ation with IOERT (Table 1). All of the patients were
female. The mean age of the patients was 32 years
(range 14–62 years). The mean follow-up period was
50 months (range 27–67 months). The tumors were lo-
cated intra-tendinously in three cases and peri-
tendinously with adhesion to the tendon in two cases.
No patients had distant metastasis. The mean tumor size
was 3.1 cm (range 0.7–4 cm). The histological diagnoses
were clear cell sarcomas (n = 2) and synovial sarcoma
(n = 1), desmoid (n = 1), and myxofibrosarcoma (n = 1).
The involved tendons were flexor/extensor of the distal
forearm (n = 2), the calcaneal tendons (n = 2), and the tibi-
alis posterior tendon (n = 1). Two of five operations were
additional excisions after intra-lesional resection at an-
other hospital. One desmoid patient was a recurrent case
who had undergone three previous surgeries. Adjuvant
chemotherapy was performed in cases 2 and 3. The study
was performed in accordance with the ethical standards of
the institutional responsible committee on human experi-
mentation and with the Helsinki Declaration of 1975, as
revised in 1983. All patients provided written informed
consent before enrolment in the study.
Surgical procedures, IOERT, and post-operative
management
The lesion was isolated and separated from the normal
tissues in the axial plane with a wide surgical margin,
maintaining the continuity of proximal and distal normal
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tissue. After the elevation of the tumor mass, including
the tendon and nerve, from the tumor bed, 6-mm-thick
lead boards, which were covered with a sterile drape,
were inserted beneath the tumor mass to shield the nor-
mal tissue (Fig. 1a). The wet gauze was used as a layer of
low density material to protect the braking X-ray. The
patients were transferred to the radiotherapy department
after the affected limbs were wrapped in sterilized plastic
bags (Fig. 1b), and 25–50 Gy of 12 MeV electrons were
delivered by a linear accelerator (Novalis TX, Brain LAB,
Feldkirchen, Germany). Using the linear-quadratic (LQ)
model (assuming an alpha/beta of three for the normal
soft tissue surrounding the tumor), a single dose of 25,
35, and 50 Gy corresponded to an equivalent dose in 2-
Gy fractions (EQD2) of 140, 266, and 530 Gy, respect-
ively [29]. An appropriately sized cone was used to ob-
tain a 3-cm longitudinal safety-margin for the irradiation
field. After irradiation, the patients were returned to the
operation room, and underwent the marginal/intra-
lesional resection of the tumor, preserving the tendon
and nerve (Fig. 1c) under general anesthesia. When the
muscle was included in the irradiation field, the muscle
Table 1 The clinical details of the patients









1 14 f Desmoid Forearm Recurrence
(three times)
FDS, FDP Intra-tendinous 4 Intermediate No No
2 21 f Clear cell sarcoma Leg Primary Calcaneal
tendon
Intra-tendinous 4 High grade No Yes





Peri-tendinous 0.7 High grade No No
4 36 f Clear cell sarcoma Ankle Primary TP Intra-tendinous 3 High grade No Yes
5 62 f Myxofibrosarcoma Forearm Inadequate
resection at
initial hosp.
EDC Peri-tendinous 4 High grade No No
FDS flexor digitorum superficialis, FDP flexor digitorum profundus, TP tibialis posterior, EDC extensor digitorum communis
Fig. 1 Surgical procedure and post-operative limb function in case 2, (a) T2 weighted-MR image showing clear cell sarcoma located intra-tendinously
at calcaneal tendon. b After the elevation of the tumor mass, including the tendon and nerve from the tumor bed, a 6-mm-thick lead boards were
inserted beneath the tumor mass to shield the normal tissue (c). The patients were transferred to the radiotherapy department after the affected limbs
were wrapped in sterilized plastic bags, and 35–50 Gy of 12 MeV electrons were delivered. d After irradiation, the patients were returned to
the operation room, and underwent the marginal/intra-lesional resection of the tumor, preserving the tendon and nerve. e The soft tissue
defect was then reconstructed using a free musculocutaneous flap. The photographs at the final follow-up time showing the normal ankle
movement (f and g) and ability of stand on toe (h)
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was resected as much as possible. If necessary, the soft
tissue defect was then reconstructed using a pedicled or
free musculocutaneous flap (Fig. 1d).
After the operation, all of the patients were kept
immobilized with the extremity in a bulky dressing for
the first 12 h. Thereafter, the patients started a gentle ac-
tive range of motion (ROM) exercise. Extensive rehabili-
tation was started after confirming the survival of the
flap on post-operative day 10. Full weight bearing was
permitted at 3 weeks after surgery in cases 2, 3, and 4.
Assessment
The complications, local recurrence, oncological result,
and functional outcome were evaluated. The functional
assessments were performed using the Musculoskeletal
Tumor Society (MSTS) scoring system [30]. The Radi-
ation Therapy Oncology Group (RTOG) criteria were
used to analyze the toxicity [15].
Results
In all of the cases, an appropriately sized cone was used
to obtain a 2-cm longitudinal safety-margin for the
irradiation field. After irradiation, the tumor was sur-
gically resected with the marginal margin (case 4) or
intra-lesional margin (cases 1, 2, 3, and 5) (Table 2).
The median follow-up period was 56 months (range
27–67 months).
For one desmoid patient, the entire operation was per-
formed under general anesthesia (case 1). A patient
whose tumor was located at the forearm (case 5) started
the procedure under a supraclavicular brachial plexus
block, and the procedure was started under lumbar
anesthesia in three patients with leg tumors (cases 2, 3,
and 4). However, after the patients returned to the oper-
ation room following the IOERT, the tumor resection
and reconstruction of the soft tissue defect were per-
formed under general anesthesia. A free vascularized
latissimus dorsi flap was used to reconstruct the soft tis-
sue defect in cases 2, 3 and 5; a localized pedicle muscu-
locutaneous flap was used in case 4. A patient with
synovial sarcoma of the distal leg, who received add-
itional excision after inadequate resection at the initial
hospital (case 3), showed partial necrosis of the free vas-
cularized latissimus dorsi flap and required secondary
minor suturing.
Local recurrence was observed at the region outside of
the irradiated field in the desmoid patient (case 1). Case
2 incidentally underwent an incisional biopsy of the cal-
caneal tendon at 61 months after the operation because
she hoped to have cosmetic surgery to improve the ap-
pearance of operation site. A pathological examination
showed that the patient was recurrence-free and also
demonstrated the regeneration of the tenocytes of the ir-
radiated calcaneal tendon. None of sarcoma patients had
local recurrence or distant metastasis.
Cases 1 and 5 showed post-operative restricted ROM
of the wrist joints; however, the restriction was mild
(RTOG criteria: grade 1). No cases of neuropathy, bone
necrosis, vascular obstruction, and lymphatic edema
were observed.
The mean limb function scores, which were deter-
mined according to the MSTS scoring system, were
87 % in the patients with a tumor of the upper extrem-
ities and 100 % in the patients with a tumor of the lower
extremities.
Discussion
The surgical excision of sarcomas involving the tendons
sometimes leads to severe functional disability [1, 4–6].
We showed the successful clinical outcomes of minim-
ally invasive surgery using IOERT for extremity STS in-
volving the tendon. Although the current study is only
a pilot study with a small number of patients, the
results show that the procedure has the potential to be-
come a standard minimally invasive therapy for selected
patients.
IOERT has several advantages over traditional EBRT.
It allows the radiotherapist to create a highly conformal
treatment field. It also allows for the delivery of higher
doses than EBRT because it is less toxic to the normal



















1 25 Gy 15 8 × 3 Positive No 63 AWD 77 rec., restricted ROM
of the wrist (grade 1)
2 35 Gy 15 12 × 4 Positive Free vascularized flap 67 CDF 100 None
3 35 Gy 10 8 × 4 Positive Free vascularized flap 56 CDF 100 Partial flap necrosis
4 50 Gy 10 8 × 4 Negative Pedicle flap 36 CDF 100 None
5 35 Gy 15 10 × 4 Positive Free vascularized flap 27 CDF 97 Restricted extension
of the wrist joint
Margin status: surgical margin when tumor was resected
AWD alive with disease, CDF continuous disease free, rec. recurrence, ROM range of motion, ISOLS Scoring System of International Society of Limb Salvage, RTOG
radiation therapy oncology group
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tissue [17, 23, 26, 28, 31–34]. In conventional IOERT,
the electron beam is delivered (with the surrounding
normal tissue shielded by a lead cone) to the affected
site after the excision of the tumor with a marginal,
intra-lesional, or wide margin. The most important point
of the current study is that the IOERT was applied to
salvage the tendon prior to the resection of the peri-/
intra-tendinous tumor. In the current study, IOERT was
delivered with a wide margin, and the surrounding tissue
was completely shielded with a lead board and applica-
tor; the tumor was then excised with a marginal or
intra-lesional margin. Thus, the current surgical proced-
ure should be distinguished from conventional IOERT,
which is applied after the resection of the tumor with an
aim of reducing local recurrence.
There are few reports on the use of IORT as a minim-
ally invasive treatment of the affected limb in patients
with localized sarcoma. A group at Kyoto University first
reported the application of IORT for extremity osteosar-
coma [35, 36]. The lesion was isolated and separated
from the normal tissues with a wide margin in the axial
plane, maintaining the continuity of the proximal and
distal normal tissue, and irradiation (45–70 Gy) was
administered with an electron beam (12–30 MeV) or X-
rays (10 MV). The irradiated tumor was generally left
without excision. Twelve of 33 patients showed post-
operative local recurrence. However, only one of the 12
patients showed recurrence in the irradiated field. The
concept of the clinical study performed at Kyoto University
was identical to our current study.
The biological effectiveness of delivering a dose in a
single fraction is not completely understood. The tool
most commonly used for the quantitative prediction of
dose/fractionation dependencies in radiotherapy is the
mechanistically based LQ model [29]. Using the LQ
model and assuming an alpha/beta of three for the nor-
mal soft tissue surrounding a tumor, a single dose of
25 Gy corresponded to an EQD2 of 140 Gy. None of
the sarcoma patients had local recurrences or distant
metastasis. In case 2, the examination of a biopsy sam-
ple confirmed the absence of recurrence. Thus, 35–
50 Gy might have been a radical dose in the current
series. Further study and a long-term follow-up period
are warranted.
The IOERT dose was carefully determined, so that it
would achieve a biological cure while minimizing the
damage to the soft tissue, such as the muscle, tendons,
and peripheral nerves [37–40]. The adverse effects on
the muscle were most critical, since IOERT was not ap-
plied to lesions that included a major nerve (such as the
sciatic nerve or brachial plexus) in the current series.
Radiation-induced muscle injury was characterized by a
loss of muscle fiber, decreased fiber size, severe vessel le-
sions, hemorrhage, inflammation, coagulation necrosis,
and fibrosis [37, 39]. In the context of clinical studies,
IOERT is usually combined with EBRT with a dose
range of 10–12 Gy for R0-R1 resections and 15–20 Gy
for R2 resections (gross macroscopic residual disease)
[37–40]. In the current series, case 5 showed mildly re-
stricted ROM of the wrist joints. Because this patient
underwent IOERT during additional wide excision after
unplanned tumor resection, the flexor muscle of the dis-
tal forearm was included in the irradiation field to avoid
recurrence in the contaminated area. However, the
radiation-induced muscle injury did not cause any sig-
nificant functional disability even in case 5, because the
tumors were located at the distal extremities, which in-
clude only a small amount of muscle fiber. Furthermore,
the muscle fiber included in the irradiation field was
resected as much as possible. These findings suggest that
this surgical procedure should be indicated only for tu-
mors located in the distal extremities.
In our institute, it was necessary to transfer the patient
from the operation room to the radiation treatment
room. This process requires close cooperation between
nursing staff, anesthesiologists, surgeons, and radiation
oncology staff. To reduce the complications of IOERT,
lumbar anesthesia/scalene block anesthesia was adminis-
tered until the patients returned from the radiation
treatment room (with the exception of one pediatric pa-
tient; case 1). The radiation oncologist and surgeons
could therefore maintain direct visual and video contact
with the patient. To ensure the smooth performance
of this complicated procedure, it is recommended that
it be thoroughly discussed with the anesthesiologist
prior to surgery.
In one patient (case 1), local recurrence was observed
outside of the irradiated field. This patient had a des-
moid tumor which recurred three times after resection.
Thus, the recurrence of this case was not due to the
current surgical procedure; rather, it was due the patho-
logical character of the desmoid tumor. Case 1 showed
the restricted ROM of the wrist joints after surgery due
to repeated surgery for desmoid tumors. The most crit-
ical problem associated with conventional EBRT is that
it often causes a number of common, well-described side
effects, such as severe muscle fibrosis, neuropathy, joint
contracture, vascular obstruction, and lymphatic edema
[14]. These adverse effects of EBRT sometimes comprom-
ise the quality of life of patients. However, in the current
series of patients who underwent IOERT, no severe com-
plications were observed. A long-term follow-up study is
warranted.
Because the margin status is reported to be the most
important prognostic factor for the local control of
STS, the elevation of the tumor mass with a completely
negative margin from the surrounding tissue is neces-
sary before IOERT is administered. Thus, this surgical
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procedure must be carefully indicated for selected
patients.
Conclusions
When an STS involving a tendon is located at the distal
part of an extremity, a wide excision usually results in
severe functional disability. We therefore developed a
minimally invasive surgical technique using IOERT to
reduce the incidence of post-operative functional disability
in patients with peri-/intra-tendinous STS. IOERT was
delivered with a wide margin under the complete shield of
the surrounding tissue using a lead board and applicator.
The tumor was then excised with a marginal or intra-
lesional margin maintaining the tendon continuity. We
showed the successful clinical outcomes of this minimally
invasive surgery.
Although the current study is only a pilot study with a
small number of patients, it has the potential to become
a standard therapy for selected patients. A further study
with a long-term follow-up period is necessary.
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